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Abstract
Background: During the COVID-19 pandemic, reductions in healthcare utilization are reported in different contexts.
Nevertheless, studies have not explored specifically gender disparities in access to healthcare in the context of
COVID-19.
Methods: To evaluate gender disparities in access to medical in Chile we conducted an interrupted time series
analysis using segmented regression. The outcome variable was the number of weekly confirmed cases of a set of
oncologic and cardiovascular time-sensitive conditions at a national level. The series contained data from weeks 1
to 39 for 2017 to 2020. The intervention period started at week 12. We selected this period because preventive
interventions, such as school closures or teleworking, were implemented at this point. We estimated the level effect
using a dummy variable indicating the intervention period and slope effect using a continuous variable from weeks
12 to 39. To test heterogeneity by gender and age group, we conducted a stratified analysis.
Results: We observed a sizable reduction in access to care with a slowly recovery for oncologic (level effect 0.323;
95% CI 0.291–0.359; slope effect 1.022; 95% CI 1.016–1.028) and cardiovascular diseases (level effect 0.586; 95% CI
0.564–0.609; slope effect 1.009; 95% CI 1.007–1.011). Greater reduction occurred in women compared to men,
particularly marked on myocardial infarction (level effect 0.595; 95% CI 0.566–0.627 versus 0.532; 95% CI 0.502–0.564)
and colorectal cancer (level effect 0.295; 95% CI 0.248–0.35 versus 0.19; 95% CI 0.159–0.228). Compared to men, a
greater absolute reduction was observed in women for oncologic diseases, excluding sex-specific cancer, (1352;
95% CI 743–1961) and cardiovascular diseases (1268; 95% CI 946–1590).
Conclusion: We confirmed a large drop in new diagnoses for time-sensitive conditions during the COVID-19
pandemic in Chile. This reduction was greater for women. Our findings should alert policy-makers about the urgent
need to integrate a gender perspective into the pandemic response.
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Background
The COVID-19 pandemic reduced the utilization of
health care services, similarly to the phenomena reported
in previous epidemic outbreaks, like SARS [1], MERS [2],
and Ebola [3]. In the current pandemic, studies have
shown a decrease in the frequency of different interven-
tions like surgeries (electives or not) and hospital admis-
sions, including specific time-sensitive conditions, such as
acute coronary syndrome [4, 5], myocardial infarctions [6,
7], stroke [8–11] and cancer [12–17].
Although it has been largely studied that gender im-
pacts access to healthcare [18–20], gender differences in
access to healthcare have been scarcely examined during
the COVID-19 pandemic. While most studies have not
explored heterogeneity by gender [4, 9–15], some studies
that examine differences between men and women on
acute coronary syndrome [5, 6] and stroke [8] have not
found relevant disparities. Only one study was done in
Latin America and did not explore gender differences
[11]. To the best of our knowledge, a single research ex-
plored access differences in cancer care by gender during
the pandemic. The authors did not identify any relevant
differences, although the more considerable decrease
was for breast cancer [17].
Gender has been proposed as a structural determinant
of health, as gender norms shape social stratification,
health-related exposures and behaviors, healthcare ac-
cess, health systems, and health research [21]. Neverthe-
less, the response to outbreaks has been usually devoid
of a gender perspective, limiting the effectiveness of the
public health response [22, 23].
Gender norms and stratification influence social and
economic outcomes, which in turn could impact access to
health care [24]. First, evidence has demonstrated that
school closure and mandatory confinement have increased
caregiving responsibilities in families, which traditionally
fall on women, producing significant disruption in their
daily lives compared with men [25]. Second, as there is a
general reduction in the availability of health services, gen-
der bias that usually affects access for women, especially
to cardiovascular diseases, may increase [26]. Finally, dur-
ing the pandemic, employment was impacted, and many
people suffered income reduction. As women are overrep-
resented in informal jobs, they experienced higher un-
employment rates and a more significant reduction in
working hours and salaries compared with men during
the pandemic in different contexts [27, 28]. Also, COVID-
19 has increased levels of gender violence, and reproduct-
ive health is usually not prioritized during emergencies
[24], potentially reducing access to relevant diagnostic ser-
vices such as smear tests for cervical cancer. Furthermore,
it is important to consider in this framework the intersec-
tions that each of these areas has with other conditions
such as age, socioeconomic level, ethnic background,
migration status, and others, which may modify their im-
plications [29].
This study aims to evaluate disparities between men and
women in access to medical care in Chile during the
COVID-19 pandemic. We focus on severe and time-
sensitive group conditions (cardiovascular diseases and
cancer) with guaranteed access in the context of the Chil-
ean health system. As observed in other countries, we hy-
pothesized a large drop in both group conditions
diagnosis, but with a more significant decrease in women.
Methods
Study setting
In 2005 Chile implemented a Health Reform which in-
cluded the National Explicit Health Guarantees Regime
(“AUGE”, nowadays “GES” - explicit guarantees in
health-), a set of guarantees aimed to ensure access to
timely (opportunity guarantee), affordable, and quality
services for people of both insurance systems predomin-
ant in Chile (public, National Health Fund - FONASA -,
and private, ISAPRES), for 56 health conditions, which
have been amplified to 85 nowadays [30]. During the
current pandemic, the obligation for FONASA and
ISAPRES to comply with the Explicit Guarantee of op-
portunity established for the health problems was sus-
pended for up to 1 month since the 8th of April, except
for severe conditions included in this study such as acute
myocardial infarction, stroke, and cancers.
Before the onset of the pandemic, Chilean women
used more healthcare services than men. They declared
a worse self-perception of their health status and a
greater number of healthcare needs [31]. In relation to
health conditions included in GES, women have a larger
waiting time than men, especially in the age group be-
tween 35 to 49 years [20]. For acute myocardial infarc-
tion, women in Chile have higher in-hospital mortality
and a lower probability of receiving treatment of proven
clinical efficacy compared to men [32].
Variables conceptualization
Gender
Sex and gender are highly entangled, and therefore is
difficult to separate them for analysis [33]. In this study,
we state that the measured differences in access to
healthcare by sex are explained mainly by gender norms.
First, because the role of gender in access to healthcare
has been previously studied as a relevant factor [18–20].
Second, because it seems less plausible that the varia-
tions between females and males in the utilization before
and after the pandemic are due to biological characteris-
tics. Therefore, and following other authors who choose
the term gender to account for social and structural fac-
tors [33], hereafter the manuscript refers to “gender” for
the studied categories of women and men.
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Health care utilization
According to Levesque’s model of health care accessibil-
ity [34], we conceptualize health care utilization as the
result of a dynamic interplay between individuals and
services. In this model, access is defined as an opportun-
ity to reach and obtain appropriate health care services
in situations of perceived need for care. Five dimensions
of health services explain accessibility: approachability,
acceptability, availability and accommodation, affordabil-
ity, and appropriateness. Each of these dimensions is re-
lated to an individual ability to generate access: the
ability to perceive, ability to seek, ability to pay, and abil-
ity to engage. Health care access barriers (or facilitators)
can appear in each dimension and occur in a cumulative
manner. During the pandemic, emerging barriers de-
creased accessibility to health care services, affecting in-
dividuals (e.g. decrease of acceptability due to fear of
contagion) and services (e. g. decrease of availability due
to human resources diversion) reducing health care
utilization. Such barriers can be different in type and in-
tensity based on gender-roles.
Data sources
We obtained data from the National Health Fund
(Fondo Nacional de Salud - FONASA) which finances
all public hospitals in Chile and provides health coverage
to nearly 15 million inhabitants (75% of the Chilean
population). We selected a set of nine time-sensitive
conditions included in the National Explicit Health
Guarantees Regime (“AUGE”): two acute cardiovascular
diseases (stroke and myocardial infarction) and seven
cancers (gastric cancer, colorectal cancer, lymphoma,
leukemia, cervical cancer, breast cancer, and testis can-
cer). We selected both group conditions because they
encompass the two major causes of death in Chile. Add-
itionally, delayed care for time-sensitive conditions, such
as major cardiovascular events and cancer, can lead to
an increased risk of long-term disability and premature
death. Also, the demand for acute cardiovascular dis-
eases is inelastic so short-term variations indicate severe
disruptions in health services utilization [35].
The attending physician registers every public-insured
patient with a medical diagnosis of these conditions as a
confirmed case. National clinical guidelines standardize
the diagnostic process for each disease, reducing practice
variation and improving reporting quality. A confirmed
case report is mandatory by law for healthcare providers.
A description of case definitions included in the Na-
tional Clinical Guidelines is available in the Supplemen-
tary File 1 (Table S1).
Analysis
We conducted an interrupted time-series analysis using
a segmented regression [36]. Due to the count nature of
the data (number of cases diagnosed per week), we fitted
generalized linear models with a Negative Binomial dis-
tribution. The outcome variable was the number of con-
firmed cases for the following diseases: stroke (includes
transient ischemic attack), myocardial infarction, all car-
diovascular diseases (stroke plus myocardial infarction),
gastric cancer, colorectal cancer, lymphoma, leukemia,
cervical cancer (includes dysplasia), breast cancer, tes-
ticular cancer, and all cancers.
The series contained data from epidemiological weeks
1 (December 30th to January 5th) to 39 (September 21th
to 27th) for the years 2017 to 2020 (156 weeks). The
intervention period started at week 12 (March 16th to
22th). We selected this period because most of the pub-
lic health interventions implemented during the pan-
demic, including school closures and remote working
recommendations, started at this point (March 15th).
Also, in that period started a process of cessation of
elective surgeries and centralization of acute beds by the
Ministry of Health. Interventions and dates details are
available in the Supplementary File 1 (Table S2).
The model was defined as:
Log Y dtð Þ ¼ Log Pdtð Þ þ β0 þ β1timeþ β2intervention
þ β3interventiontfter þ β4ageþ Zdt þ ε
With Ydt the number of confirmed cases of disease d
in week t, Pdt the population (number) of public health
beneficiaries by age-group, β1 is the time elapsed since
the start of the study (in weeks), β2 is a dummy variable
indicating the intervention period (coded 1), β3 is the
time elapsed since the beginning of the intervention (in
weeks), β4 adjust for the effect of age (20 to 29 years, 30
to 39 years, 40 to 49 years, 50 to 59 years, 60 to 69 years,
70 to 79 years, 80 years, and more), Zdt a vector of ad-
justment co-variable for weekly and yearly seasonal fixed
effect terms and ε is an error term.
To test heterogeneity, we did stratified analysis by gen-
der and gender-age. As a sensitivity analysis, we fitted
unadjusted and adjusted models for all cancers, after ex-
cluding sex-specific cancers (breast cancer, cervical can-
cer, and testicular).
We reported the mean and standard deviation for de-
scriptive analysis and incidence rate ratios (IRR) and ab-
solute effects (counts) with 95% confidence intervals for
regressions models. We used STATA 16.0 for analyses.
Results
We analyzed a total of 156 weeks with 327,477 cardio-
vascular events (83,034 strokes and 244,443 myocardial
infarction) and 137,700 cancer diagnoses (23,135 gastric
cancers, 24,579 colorectal cancers, 5,290 lymphomas,
2535 leukemia, 42,143 cervical cancers, 37,443 breast
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cancers, and 2,575 testicular cancers) during the study
period (Table S3, Supplementary File 1).
Compared to previous years (2017–2019), after week
12 (March 16, 2020) an immediate downward trend in
the number of events was confirmed for all diseases
(Fig. 1). In the oncologic diseases group, a smaller de-
crease occurred for lymphoma and leukemia (Fig. 1). In
the cardiovascular diseases group, we observe more sub-
stantial reductions for myocardial infarction compared
to stroke. Previous to the observed downward, trends
were parallel for all studied diseases. The drop observed
at week 38 is related to the national holiday. When ana-
lyzed by gender, women showed a greater impact on
their access compared with men for both diseases
groups during the study period (Fig. 2).
In our model, we confirmed a larger immediate reduc-
tion (level effect) for cancer conditions (0.323; 95% CI
0.291–0.359) compared to the cardiovascular events
(0.586; 95% CI 0.564–0,609). In contrast, the post inter-
vention slope was larger for cancer conditions (1.022;
95% CI 1.016–1.028) than cardiovascular events (1.009;
95% CI 1.007–1.011) (Table 1). Among cancer condi-
tions, a greater immediate reduction was observed in
colorectal cancer (0.229; 95% CI 0.199–0.265), gastric
cancer (0.306; 95% CI 0.253–0.371), cervical cancer
(0.335; 95% CI 0.287–0.392) and breast cancer (0.336;
95% CI 0.293–0.385). A greater post intervention slope
was observed in colorectal cancer (1.036 95% CI 1.028–
1.043), breast cancer (1.028 95% CI 1.021–1.036) and
gastric cancer (1.022 95% 1.011–1.032). This suggest a
rapid recovery trend for this diagnosis after the initial
abrupt reduction for this conditions. In the cardiovas-
cular group, the most affected condition was myocardial
infarction (0.564 95% CI 0.539–0.589) with similar post
intervention trends. (Table 1).
A differential impact, with larger effects on women
than men, was observed across cardiovascular and onco-
logical diseases. For the former, a 6.8% (0.621 95% CI
0.593–0.65 in men and 0.553 95% CI 0.527–0.579 in
women) additional immediate reduction in access for
Fig. 1 Number of new cases diagnosed per week for each disease during the first 39 weeks of the year, 2017-2020. Points represent the average
number of events (new cases diagnosed) per week for each disease during the first 39 weeks of the year. Solid lines are the point estimate for
the fitted model. Colored areas around the lines are the 95% confidence intervals for the fitted model. In blue, the cases observed in the years
2017–2019 (used as a control group). In green, the number of patients diagnosed in 2020 (affected by the COVID-19 pandemic). The vertical line
represents the starting week of the first population-level interventions for COVID-19 in Chile (week 12)
Pacheco et al. BMC Public Health         (2021) 21:1802 Page 4 of 9
cardiovascular events in women compared with men
was evident. For the latter, a further non-significant 5.2%
immediate reduction (0.364; 95% CI 0.315–0.408 in men
and 0.312 95% CI 0.279–0.35) in access to newly diag-
nosed cancers among females compared with males was
observed in the pandemic period. In the sensitivity ana-
lysis, differences between sexes in the cancer group in-
creased after excluding sex-specific cancers such as
breast, cervical, and testicular cancers. In this analysis, a
bigger impact on access was confirmed among women
(0.351; IC 95% 0.302–0.408 in men and 0.254; IC95%
0.218–0.296 in men). Differences in post-intervention
trends were similar in both groups. (Table 1).
When analyzed by specific cardiovascular diseases, a
greater immediate decrease in women than men took
place for myocardial infarction (0.697; 95% CI 0.649–
0.75 in men and 0.532 95% CI 0.502–0.564 in women).
When analyzed by specific oncologic diseases, a greater
immediate decrease in women than men occurred for
colorectal cancer (0.295; 95% CI 0.248–0.35 in men and
0.19; 95% CI 0.159–0.228 in women). Also, a greater im-
mediate reduction on cervical cancer (0–335 95% CI 0–
287-0.392) and breast cancer (0.336 95% CI 0.293–
0.385) compared to testicular cancer (0.469; 95% CI
0.339–0.649) was observed (Table 1). Post intervention
trends were similar for all specific cardiovascular and
oncologic diseases.
To make sense of these findings, we also present abso-
lute effects sizes. A greater absolute effect in access for
women compared to men occurred in almost all
Fig. 2 Number of new cases by sex of cardiovascular diseases and cancers, excluding sex-specific cancers, during the first 39 weeks of the year,
2017-2020. Points represent the average number of events (new cases diagnosed) per week for all cancers and cardiovascular events during the
first 39 weeks of the year. Cancers exclude sex-specific conditions such as breast, cervical, or testicular cancer to facilitate comparisons between
genders. Cardiovascular events include stroke and myocardial infarction. Solid lines are the point estimate for the fitted model. Colored areas
around the lines are the 95% confidence intervals for the fitted model. In blue, the cases observed in the years 2017–2019 (used as a control
group). In red, the number of patients diagnosed in 2020 (affected by the COVID-19 pandemic). The vertical line represents the starting week of
the first population-level interventions for COVID-19 in Chile (week 12)
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conditions (Table 2). An excess impact in women com-
pared to men was observed for oncologic (9,140; 95% CI
4,619-13,661) and cardiovascular diseases (1,268; 95% CI
946–1,590) during the 28 weeks of the pandemic in-
cluded in the study period. In the sensitivity analysis, dif-
ferences between genders persisted but were smaller
(1,352; 95% CI 743–1,916). When analyzed by specific
diseases, we found sizable differences in access for
women compared to men for myocardial infarction (729
95% CI 631–930), colorectal cancer (844 95% CI 288–
1401), gastric cancer (562; 95% CI 362–762) and stroke
(538 95% CI 250–624).
In our final analysis, we estimated relative and absolute
effects across gender and age groups for cardiovascular
Table 1 Incidence Rate Ratio for weekly confirmed cases during the pandemic period (week 12-39)a
Both sexes Men Women
Level effect Slope effect Level effect Slope effect Level effect Slope effect





























































































































aInterrupted time series analysis by sex adjusted by age, population size, and seasonality (week and year). The model includes level and slope effect terms.
Complete models are available in Supplemental material (Table S3-S5)





Excess impact on woman
Count (95%CI)
All cardiovascular diseases 9,047 (6,845 - 11,248) 10,315 (7,791 - 12,838) 1,268 (946–1,590)
Stroke (includes transient ischemic attack) 1,557 (798–2,214) 2,286 (1,428–3,144) 729 (631–930)
Myocardial infarction 7,497 (5,702 - 8,906) 8,035 (5,952 - 9,529) 538 (250–624)
All cancer 2,056 (611–3,161) 11,196 (5,229 - 17,163) 9,140 (4,619 - 13,661)
All cancer (excluding sex specific cancer) 1,863 (564–3,161) 3,215 (1,307 - 5,122) 1,352 (743–1,961)
Gastric cancer 828 (44–1,612) 1,390 (406–2,374) 562 (362–762)
Colorectal cancer 896 (348–1,444) 1,740 (636–2,844) 844 (288–1,401)
Lymphoma 128 (− 25–281) 111 (− 36–258) 17 (11–23)
Leukemia 10 (− 20–40) 15 (− 44–13) -5 (−4 - -7)
Cervical cancer (includes dysplasia) .. 5,185 (2,522 - 7,848) ..
Breast cancer .. 2,931 (784–5,078) ..
Testicular cancer 202 (−25–430) .. ..
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diseases and oncologic diseases, excluding sex-specific
cancer (Table S4). For cardiovascular diseases, we only
observed a significant immediate decrease for the 20 to
29 years’ group. A larger absolute difference for women
compared to men was observed in the older groups (527
95% CI 485–569 in the 70 to 79 years’ group and 668
95% CI 472–614 in the 80 years and older group). For
oncologic diseases, a larger immediate decrease was evi-
dent for women in all ages groups, and the greater abso-
lute difference was observed among middle-aged and
older women (426 95% CI 175–676 in 50 to 59 years’
group and 395 95% CI 364–427 in 60 to 69 years group).
Discussion
Our analysis confirmed a large drop in the access to
medical diagnosis for cardiovascular and oncologic con-
ditions in Chile during COVID-19 pandemic as previous
studies have shown [4–15], This decrease was more sig-
nificant for oncologic than cardiovascular diseases. Also,
we confirmed our hypothesis of sizable gender dispar-
ities in the impact of the pandemic on access to medical
care. A large group of time-sensitive conditions was af-
fected by this differential effect, even though healthcare
access for these conditions is guaranteed by law in Chile.
This finding is worrisome because delaying care for
these severe conditions can lead to long-term disability
and - eventually - premature mortality.
Because cardiovascular diseases and cancers have dif-
ferent etiological mechanisms, it is highly implausible to
explain this finding through biological mechanisms.
While a stroke and myocardial infarction could increase
after COVID-19 infection [37, 38], a reduction in the
number of diagnosed cardiovascular events is probably
explained by decreased access to healthcare. If men are
more prone to COVID-19 [39], this could explain, at
least partially, that the decline in stroke and myocardial
infarction in males could be smaller compared with
women. Although, this explanation cannot be given in
cancer because these diseases do not share the same
causes and acute changes in cancer incidence are un-
likely to be attributable to COVID-19 infection. In this
setting, a reduced number of newly diagnosed cancers,
particularly among women, is a clear marker of reduced
access and unmet needs.
Gender norms and hierarchies could explain this
wide effect better. During the pandemic, women faced
more health care barriers than men. Income decrease
due to work hours reduction [27] and higher un-
employment [28] reduced women’s ability to pay for
health care. Also, interventions to reduce COVID-19
transmission, such as school closures, increased the
care burden in families reducing women’s time avail-
ability to seek care [25]. This could explain the
greater differential effect observed on diseases that
require scheduled appointments for testing (e.g., colo-
rectal, cervical, gastric, and breast cancer).
From a health services perspective, the diversion of re-
sources (health personnel, hospital beds, among others)
to cope with the pandemic reduced provider’s availability
for cancer and cardiovascular care. Previous to the pan-
demic, women waited more time than men to access
care for these health conditions [20]. For acute myocar-
dial infarction, the treatment of women was proven sub-
optimal compared to men [32]. These gender biases
could be aggravated in the context of health services
scarcity, differentially affecting the ability to reach and
use health care services in women [21].
Finally, fear of SARS-CoV-2 contagion in medical set-
tings could reduce the acceptability of health services,
decreasing the user’s ability to seek care. The reduction
of health services utilization showed a rapid onset start-
ing when the first control measures were established.
This sudden decrease preceded the stay-at-home man-
dates (March 26) and lockdowns (May 13). Also, it pre-
ceded the period of the highest incidence of cases (May–
June). This pattern could be explained by user fear trig-
gered by extensive media coverage about death overseas
and the uncertainty of a new infectious disease during
the first weeks of the pandemic. A Chilean survey evi-
denced that this fear was more frequent in women than
in men [40]. It is unclear why women suffered more fear
but this could partly explain immediate differences in
access to health care.
Women’s health access disruption has been observed
for other conditions. A recent systematic review con-
cluded that maternal and fetal outcomes worsened dur-
ing the COVID-19 pandemic with an increase in
maternal deaths, stillbirth, ruptured ectopic pregnancies,
and maternal depression [41]. Similar disruptions were
observed for contraception and safe abortion services
[24]. According to these findings, an urgent call to pro-
tect sexual and reproductive care and to include a gen-
der perspective in the pandemic response was raised by
multiple humanitarian organizations [42].
As strengths, this is the first study from Latin America
that explores access by gender to medical diagnosis dur-
ing the COVID-19 pandemic. To test our hypothesis, we
used a rich, comprehensive, and reliable national data-
base where cases were defined based on standardized
diagnostic processes. We select a variety of severe time-
sensitive conditions to avoid generalization based on an-
ecdotal evidence. Moreover, we tested different models,
maintaining our conclusions unchanged.
This study has several limitations. First, we use admin-
istrative data, which might be subject to underreporting
during the pandemic. Nevertheless, confirmed case re-
ports have been mandatory for healthcare providers
since 2004. Moreover, they are used for health claim
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payments in the Chilean health system, therefore making
it less likely that reduced reporting could explain the ob-
served effect. Second, due to the data codification, this
study only considers two categories for sex and gender
(female and male). This dichotomy excludes a spectrum
of gender identities and the intersex population [21]. Fu-
ture studies must explore differential effects on health
care accessibility during pandemics for broader gender
classification. Third, we cannot rule out residual con-
founding in the context of observational data. Neverthe-
less, due to the characteristic of the exposure of interest
(the pandemic) is unlikely that better data could be ob-
tained using alternative sources or study designs. We
controlled confirmed cases by population and age in our
models and included seasonal adjustments by week and
year to control for unobserved time-specific confounding
factors. The use of previous year trends as a control for
the same observational units allows adjustment for con-
founding, but since no parallel control group was
available adjustment for other time-variant effects con-
comitants to the pandemic was not feasible.
Conclusion
In our study, we confirmed a large drop in the medical
diagnosis for time-sensitive conditions during the
COVID-19 pandemic in Chile. Additionally, we demon-
strate that women were far more affected compared to
men. This differential effect by gender was observed for
a broad group of time-sensitive conditions. As re-
searchers have posed [22, 23], our findings should alert
policy-makers about the urgent need to integrate a gen-
der perspective into outbreak response. If school closure
has a role in the observed differential effect, increasing
the number of health care services will not be enough to
shorten these disparities between genders. Services
provision should be reachable, especially for women who
are raising children or have other caregiver responsibil-
ities and reduce economic barriers. Also, health profes-
sionals should be aware of this situation and encouraged
through clinical guidelines to reduce current gender bias
in their clinical practice.
Future research must evaluate the consequences of ac-
cess reductions on disability and premature death. The
observed effect occurred in a set of severe time-sensitive
conditions where care delays could worsen prognosis.
Additionally, we need to know the causes, which could be
informed through surveys and innovative ways to provide
care for these diseases during the actual pandemic.
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